Brecanavir

Brecanavir (GW640385) is a novel, potent HIV protease inhibitor.

Product Specifications

CAS Number

[313682-08-5]

Product Name Alternative

GW640385

UNSPSC

12352005

Target

HIV Protease

Type

Reference compound

Related Pathways

Anti-infection; Metabolic Enzyme/Protease

Applications

COVID-19-anti-virus

Field of Research

Infection

Assay Protocol

https://www.medchemexpress.com/brecanavir.html

Purity

98.79

Solubility

DMSO : 17.6 mg/mL (ultrasonic; warming)

Smiles

CC1=NC(COC2=CC=C(C[C@H](NC(O[C@H]3CO[C@@H]4[C@H]3CCO4)=O)[C@H](O)CN(S(=O)(C5=CC=C6C(OCO6)=C5)=O)CC(C)C)C=C2)=CS1

Molecular Formula

C33H41N3O10S2

Molecular Weight

703.82

References & Citations

[1]Ford SL, Reddy YS, Anderson MT, et al. Single-dose safety and pharmacokinetics of brecanavir, a novel human immunodeficiency virus protease inhibitor. Antimicrob Agents Chemother. 2006;50 (6) :2201-2206. |[2]Reddy YS, Ford SL, Anderson MT, Murray SC, Ng-Cashin J, Johnson MA. Safety and pharmacokinetics of brecanavir, a novel human immunodeficiency virus type 1 protease inhibitor, following repeat administration with and without ritonavir in healthy adult subjects. Antimicrob Agents Chemother. 2007;51 (4) :1202-1208.